Order Article Reprints

de Lima SKS, Cavallone ÍN, Serrano DR, Anaya BJ, Lalatsa A, Laurenti MD, Lago JHG, da Silva Souza DC, Marinsek GP, Lopes BS, et al. Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis. Pharmaceutics. 2023; 15(11):2602. https://doi.org/10.3390/pharmaceutics15112602

de Lima, Sarah Kymberly Santos, Ítalo Novaes Cavallone, Dolores Remedios Serrano, Brayan J. Anaya, Aikaterini Lalatsa, Márcia Dalastra Laurenti, João Henrique Ghilardi Lago, Dalete Christine da Silva Souza, Gabriela Pustiglione Marinsek, Beatriz Soares Lopes, and et al. 2023. "Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis" Pharmaceutics 15, no. 11: 2602. https://doi.org/10.3390/pharmaceutics15112602

de Lima, S. K. S., Cavallone, Í. N., Serrano, D. R., Anaya, B. J., Lalatsa, A., Laurenti, M. D., Lago, J. H. G., da Silva Souza, D. C., Marinsek, G. P., Lopes, B. S., de Britto Mari, R., & Passero, L. F. D. (2023). Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis. Pharmaceutics, 15(11), 2602. https://doi.org/10.3390/pharmaceutics15112602